At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 20 enrolled
Drug / intervention
Deferiprone extended release +1 moredrug
Likely dose
Deferiprone extended release 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Single-dose Pharmacokinetic Study of Deferiprone Extended Release Tablets Versus Ferriprox Immediate Release Tablets Under Fasting and Fed Conditions in Healthy Volunteers
In Brief
A Phase 1 clinical trial evaluating Deferiprone extended release and Deferiprone immediate release for Healthy. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to look at the pharmacokinetics of a new formulation of deferiprone (deferiprone extended release tablets) under fed and fasting conditions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesCanada
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJun 2015
First PostedJun 2015
Primary CompletionAug 2015
TodayJul 2026
First PostedJun 8, 2015
Enrollment StartJun 1, 2015
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.1 years ago
Interventions
Deferiprone extended releasedrug
Deferiprone 1000 mg extended release tablet formulation
Deferiprone immediate releasedrug
Ferriprox (deferiprone) 500 mg immediate release tablet formulation